The testosterone levels of healthy men decline as they get older. As sleep quality and quantity typically decrease with age, objectively measured differences in the amount of sleep a healthy older man gets can affect his level of testosterone in the morning, according to a study published in the April 1st issue of the journal SLEEP.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug.
The BMA is launching updated guidance on withholding and withdrawing life-prolonging treatment, to take into account the major changes for patients and doctors that will come into force when the Mental Capacity Act is implemented in England and Wales in April and October 2007.
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center – led New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.
US Presidential spokesman Tony Snow’s surgery to remove a small growth showed that his cancer has returned, the White House said.
For all the current emphasis on standardized testing and teaching requirements, the quality of elementary school instruction is mediocre at best, according to a study from the NICHD Study of Early Child Care and Youth Development study published in the March 30 issue of Science magazine.
Mental health services in England and Wales have been accused of being institutionally racist. In this week?s BMJ, two senior doctors say that, although services are pioneers in moving towards equity, they have some way to go before they meet the challenges of a multi-cultural society.
The Honourable Tony Clement, Federal Minister of Health, and the Honourable George Smitherman, Health Minister of Ontario, announced that Ontario will establish a Patient Wait Times Guarantee for cataract surgery by January 1, 2009, to be supported by $205 million in federal funding.
Commenting on the survey of directors of social services about the impact of NHS deficits, published by the LGA, David Stout, director of the NHS Confederation’s Primary Care Trust Network, said:
The U.S. Food and Drug Administration (FDA) announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients? heart valves.